Announcement

Social Media

Meeting Flyer & Brochure

Main Topics

  • Origin of Antiphospholipid Antibodies
  • Genetics of Antiphospholipid Antibodies/Syndrome
  • Mechanism(s) of Antiphospholipid Antibody-mediated Thrombosis
  • Mechanism(s) of Antiphospholipid Antibody-mediated Pregnancy Morbidity
  • Target Cells and Receptors that Interact with Antiphospholipid Antibodies
  • Definition, Epidemiology, and Natural History of Antiphospholipid Syndrome
  • Impact of Antiphospholipid Syndrome in General Population with Thrombosis and Pregnancy Morbidity
  • Association with Antiphospholipid Syndrome and Other Systemic Autoimmune Diseases (Systemic Lupus Erythematosis, Rheumatoid Arthritis)
  • Microangiopathic and Catastrophic Antiphospholipid Syndrome
  • Impact of Pediatric APS in Children with Thrombosis
  • Clinical and Prognostic Significance of “Criteria” and “Non-criteria” Antiphospholipid Antibody Tests
  • Strengths and Limitations of the Current Classification Criteria
  • Disease Measurement Criteria in Antiphospholipid Syndrome
  • Most Recent Strategies in the Treatment of Thrombosis in General Population
  • Current Treatment strategies for Non-obstetric Antiphospholipid Syndrome
  • Current Treatment strategies for Obstetric Antiphospholipid Syndrome
  • Antiphospholipid Syndrome Treatment Trends (Ongoing and Planned Interventional Studies with New Generation Oral Anticoagulants, B-cell inhibition, Complement Inhibition, Hydroxychloroquine, Statins, Peptide Therapy, and others)
  • Antiphospholipid Antibodies, Antiphospholipid Syndrome (APS), and Obstetric APS for Patients